Hisamitsu Pharmaceutical CoFSE:4530 89 Interest Coverage is 896.00 as of Nov. 2025, which is 8% above its 10-year median of 831.74. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07. Among 685 Drug Manufacturers companies, Hisamitsu Pharmaceutical Co ranks better than 92.41% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Hisamitsu Pharmaceutical Co's
Operating Income
for the
three
months ended in Nov. 2025 was 円4,480 Mil. Hisamitsu Pharmaceutical Co's Interest Expense for the
three
months ended in Nov. 2025 was 円-5 Mil.
Hisamitsu Pharmaceutical Co's interest coverage for the quarter that ended in Nov. 2025 was 896.00.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Hisamitsu Pharmaceutical Co Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Interest Coverage or its related term are showing as below:
FSE:4530'
s Interest Coverage Range Over the Past 10 Years
Min: 466.85 Med: 831.74 Max: 1196.21
Current: 853.24
FSE:4530's Interest Coverage is ranked better than 92.41% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs FSE:4530: 853.24
Hisamitsu Pharmaceutical Co (FSE:4530) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Hisamitsu Pharmaceutical Co Interest Coverage Related Terms
Hisamitsu Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Hisamitsu Pharmaceutical Co Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's Interest Coverage falls into.
Hisamitsu Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co (FSE:4530) has a Interest Coverage of 896.00 as of Nov. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is near median its historical median of 831.74. Over the past decade, Hisamitsu Pharmaceutical Co's Interest Coverage has ranged from 466.85 to 1,196.21. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #52 out of 685 companies in the Drug Manufacturers industry, placing it in the top 7.6%.
Is Hisamitsu Pharmaceutical Co's Interest Coverage too high?
Hisamitsu Pharmaceutical Co's current Interest Coverage of 896.00 is near median its 10-year median of 831.74. Over the past 10 years, this metric has ranged from a low of 466.85 to a high of 1,196.21. The Drug Manufacturers industry median Interest Coverage is 12.78. Hisamitsu Pharmaceutical Co's value of 896.00 is 6911% above this industry median. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #52 out of 685 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #52 out of 685 companies for Interest Coverage. This places Hisamitsu Pharmaceutical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.78. Hisamitsu Pharmaceutical Co's value of 896.00 is 6911% above this benchmark. Historically, Hisamitsu Pharmaceutical Co's own Interest Coverage has ranged from 466.85 to 1,196.21 over the past decade. While the company's 10-year median is 831.74 vs. the industry median of 12.78, Hisamitsu Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hisamitsu Pharmaceutical Co's current Interest Coverage of 896.00 is 6911% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current Interest Coverage is 896.00, which is near median its own 10-year median of 831.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current Interest Coverage of 896.00. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current Interest Coverage is 896.00, which is near median its 10-year median of 831.74 and 6911% above the Drug Manufacturers industry median of 12.78. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current Interest Coverage is 896.00 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.
Key valuation signals for FSE:4530:
Interest Coverage: 896.00 (near median its 10-year median of 831.74)
GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
Industry Position: 6911% above the Drug Manufacturers median (#52 of 685)
No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score
Get the complete analysis for FSE:4530
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSE:4530 has been successfully added to your 
